ABT-450
Jump to navigation
Jump to search
Indications
- hepatitis C infection
- used in combination with ritonavir, ombitasvir, dasabuvir & ribavirin
Dosage
- ABT-450 150 mg, ritonavir 100 mg, ombitasvir 25 mg QD, dasabuvir 250 mg BID, & ribavirin adjusted to body weight for 12-24 weeks
More general terms
References
- ↑ Poordad F et al ABT-450/r - Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis. N Engl J Med. April 12, 2014 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24725237 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1402869